Dacogen

Dacogen Caution For Usage

Manufacturer:

Janssen

Distributor:

Zuellig Pharma
Full Prescribing Info
Caution For Usage
Instructions for Use and Handling and Disposal: This medicinal product is for single use only. Skin contact with the solution should be avoided and protective gloves must be worn. Standard procedures for dealing with anticancer agents should be adopted. DACOGEN should be aseptically reconstituted with 10 mL of Sterile Water for Injection. Upon reconstitution, each mL contains approximately 5.0 mg of decitabine at pH 6.7 to 7.3. Immediately after reconstitution, the solution should be further diluted with 0.9% Sodium Chloride Injection or 5% Dextrose Injection to a final drug concentration of 0.15 to 1.0 mg/mL. Unless used within 15 minutes of reconstitution, the diluted solution must be prepared using cold (2°C to 8°C) infusion fluids and stored at 2°C to 8°C for up to a maximum of 4 hours until administration. Any unused product or waste material should be disposed of in accordance with local requirements.
Incompatibilities: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products. DACOGEN should not be infused through the same intravenous access/line with other medicinal products.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in